2024 ICD-10-CM Diagnosis Code T45.8X6

Underdosing of other primarily systemic and hematological agents

ICD-10-CM Code:
T45.8X6
ICD-10 Code for:
Underdosing of primarily systemic and hematological agents
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
        (T45)

T45.8X6 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of underdosing of other primarily systemic and hematological agents. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Underdosing of primarily systemic and hematological agents

Non-specific codes like T45.8X6 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for underdosing of primarily systemic and hematological agents:

  • Use T45.8X6A for initial encounter - BILLABLE CODE

  • Use T45.8X6D for subsequent encounter - BILLABLE CODE

  • Use T45.8X6S for sequela - BILLABLE CODE

Clinical Information

  • Deferoxamine

    natural product isolated from streptomyces pilosus. it forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
  • Erythropoietin

    glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.
  • Receptors, Erythropoietin

    cell surface proteins that bind erythropoietin with high affinity and trigger intracellular changes influencing the behavior of cells.
  • Folate Receptor 2

    a subtype of gpi-anchored folate receptors that is expressed in placenta and hematopoietic cells.
  • Folic Acid

    a member of the vitamin b family that stimulates the hematopoietic system. it is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.
  • Folic Acid Antagonists

    inhibitors of the enzyme, dihydrofolate reductase (tetrahydrofolate dehydrogenase), which converts dihydrofolate (fh2) to tetrahydrofolate (fh4). they are frequently used in cancer chemotherapy. (from ama, drug evaluations annual, 1994, p2033)
  • Folic Acid Deficiency

    a nutritional condition produced by a deficiency of folic acid in the diet. many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. alcohol interferes with its intermediate metabolism and absorption. folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. this deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. it is indistinguishable from vitamin b 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in b 12 deficiency do not occur. (merck manual, 16th ed)
  • Folic Acid Transporters

    proteins involved in the transport of folic acid and folate derivatives across the cellular membrane.
  • Tetrahydrofolate Dehydrogenase

    an enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and nadph to yield 5,6,7,8-tetrahydrofolate and nadph+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. (dorland, 27th ed) ec 1.5.1.3.
  • Hydroxocobalamin

    injectable form of vitamin b 12 that has been used therapeutically to treat vitamin b 12 deficiency.
  • Antigens, Differentiation, B-Lymphocyte

    membrane antigens associated with maturation stages of b-lymphocytes, often expressed in tumors of b-cell origin.
  • Argon Plasma Coagulation

    a method of tissue ablation and bleeding control that uses argon plasma (ionized argon gas) to deliver a current of thermocoagulating energy to the area of tissue to be coagulated.
  • Blood Donation

    voluntary giving of blood.
  • Blood Proteins

    proteins that are present in blood serum, including serum albumin; blood coagulation factors; and many other types of proteins.
  • Carboxypeptidase B2

    a carboxypeptidase that removes c-terminal lysine or arginine from peptides and proteins. carboxypeptidase b2 (cpb2) is released into the circulation as a proenzyme which is activated by the thrombin-thrombomodulin complex. activated cpb2 is involved in modulating a variety of processes by cleaving and inactivating various circulating proteins and peptides that are its substrates including fibrin; kinins; and anaphylatoxins.
  • Cell Membrane

    the lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.
  • Complement C1 Inhibitor Protein

    an endogenous 105-kda plasma glycoprotein produced primarily by the liver and monocytes. it inhibits a broad spectrum of proteases, including the complement c1r and the complement c1s proteases of the classical complement pathway, and the mannose-binding protein-associated serine proteases. c1-inh-deficient individuals suffer from hereditary angioedema types i and ii.
  • Curing Lights, Dental

    light sources used to activate polymerization of light-cured dental cements and dental resins. degree of cure and bond strength depends on exposure time, wavelength, and intensity of the curing light.
  • Dendritic Cells

    specialized cells of the hematopoietic system that have branch-like extensions. they are found throughout the lymphatic system, and in non-lymphoid tissues such as skin and the epithelia of the intestinal, respiratory, and reproductive tracts. they trap and process antigens, and present them to t-cells, thereby stimulating cell-mediated immunity. they are different from the non-hematopoietic follicular dendritic cells, which have a similar morphology and immune system function, but with respect to humoral immunity (antibody production).
  • Factor IX

    storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. its activated form, ixa, forms a complex with factor viii and calcium on platelet factor 3 to activate factor x to xa. deficiency of factor ix results in hemophilia b (christmas disease).
  • Factor XI

    stable blood coagulation factor involved in the intrinsic pathway. the activated form xia activates factor ix to ixa. deficiency of factor xi is often called hemophilia c.
  • Factor XI Deficiency

    a hereditary deficiency of blood coagulation factor xi (also known as plasma thromboplastin antecedent or pta or antihemophilic factor c) resulting in a systemic blood-clotting defect called hemophilia c or rosenthal's syndrome, that may resemble classical hemophilia.
  • Factor XIIIa

    activated form of factor xiii, a transglutaminase, which stabilizes the formation of the fibrin polymer (clot) culminating the blood coagulation cascade.
  • Fatty Acid-Binding Proteins

    intracellular proteins that reversibly bind hydrophobic ligands including: saturated and unsaturated fatty acids; eicosanoids; and retinoids. they are considered a highly conserved and ubiquitously expressed family of proteins that may play a role in the metabolism of lipids.
  • Fibrin Clot Lysis Time

    a measurement of the time needed for fibrinolysis to occur.
  • Granuloma, Plasma Cell

    a slow-growing benign pseudotumor in which plasma cells greatly outnumber the inflammatory cells.
  • Hemophilia B

    a deficiency of blood coagulation factor ix inherited as an x-linked disorder. (also known as christmas disease, after the first patient studied in detail, not the holy day.) historical and clinical features resemble those in classic hemophilia (hemophilia a), but patients present with fewer symptoms. severity of bleeding is usually similar in members of a single family. many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. treatment is similar to that for hemophilia a. (from cecil textbook of medicine, 19th ed, p1008)
  • Hydroxyethyl Starch Derivatives

    starches that have been chemically modified so that a percentage of oh groups are substituted with 2-hydroxyethyl ether groups.
  • Interleukin-6

    a cytokine that stimulates the growth and differentiation of b-lymphocytes and is also a growth factor for hybridomas and plasmacytomas. it is produced by many different cells including t-lymphocytes; monocytes; and fibroblasts.
  • Leukemia, Plasma Cell

    a rare, aggressive variant of multiple myeloma characterized by the circulation of excessive plasma cells in the peripheral blood. it can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.
  • Multiple Myeloma

    a malignancy of mature plasma cells engaging in monoclonal immunoglobulin production. it is characterized by hyperglobulinemia, excess bence-jones proteins (free monoclonal immunoglobulin light chains) in the urine, skeletal destruction, bone pain, and fractures. other features include anemia; hypercalcemia; and renal insufficiency.
  • Neoplasms, Plasma Cell

    neoplasms associated with a proliferation of a single clone of plasma cells and characterized by the secretion of paraproteins.
  • Orbital Pseudotumor

    a nonspecific tumor-like inflammatory lesion in the orbit of the eye. it is usually composed of mature lymphocytes; plasma cells; macrophages; leukocytes with varying degrees of fibrosis. orbital pseudotumors are often associated with inflammation of the extraocular muscles (orbital myositis) or inflammation of the lacrimal glands (dacryoadenitis).
  • Paraproteinemias

    a group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. these cells frequently secrete a structurally homogeneous immunoglobulin (m-component) and/or an abnormal immunoglobulin.
  • Plasma

    the residual portion of blood that is left after removal of blood cells by centrifugation without prior blood coagulation.
  • Plasma Cell Granuloma, Pulmonary

    a tumor-like inflammatory lesion of the lung that is composed of plasma cells and fibrous tissue. it is also known as an inflammatory pseudotumor, often with calcification and measuring between 2 and 5 cm in diameter.
  • Plasma Cells

    specialized forms of antibody-producing b-lymphocytes. they synthesize and secrete immunoglobulin. they are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (rosen et al., dictionary of immunology, 1989, p169 & abbas et al., cellular and molecular immunology, 2d ed, p20)
  • Plasma Exchange

    removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (ppf), albumin preparations, dextran solutions, saline. used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.
  • Plasma Gases

    ionized gases, consisting of free electrons and ionized atoms or molecules which collectively behave differently than gas, solid, or liquid. plasma gases are used in biomedical fields in surface modification; biological decontamination; dentistry (e.g., plasma arc dental curing lights); and in other treatments (e.g., argon plasma coagulation).
  • Plasma Kallikrein

    a peptidohydrolytic enzyme that is formed from prekallikrein by factor xiia. it activates factor xii; factor vii; and plasminogen. it is selective for both arginine and to a lesser extent lysine bonds. ec 3.4.21.34.
  • Plasma Membrane Calcium-Transporting ATPases

    calcium-transporting atpases found on the plasma membrane that catalyze the active transport of calcium from the cytoplasm into the extracellular space. they play a role in maintaining a calcium gradient across plasma membrane.
  • Plasma Membrane Neurotransmitter Transport Proteins

    a family of neurotransmitter transporter proteins that facilitate neurotransmitter reuptake into presynaptic terminals. they may play a role in regulating the intensity and duration of neurotransmission.
  • Plasma Skin Regeneration

    a cosmetic technique that uses plasma gases in therapeutic treatment to help achieve skin rejuvenation or regeneration and delay skin aging.
  • Plasma Substitutes

    any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. these substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. they are also used to treat dehydration.
  • Plasma Volume

    volume of plasma in the circulation. it is usually measured by indicator dilution techniques.
  • Plasmablastic Lymphoma

    malignant lymphoma composed of large b lymphoid cells which have the immunophenotype of plasma cells and a predilection for the oral cavity.
  • Plasmacytoma

    any discrete, presumably solitary, mass of neoplastic plasma cells either in bone marrow or various extramedullary sites.
  • Plasmalogens

    glycerophospholipids in which one of the two acyl chains is attached to glycerol with an ether alkenyl linkage instead of an ester as with the other glycerophospholipids.
  • Plasmapheresis

    procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. plasmapheresis is also employed for therapeutic use.
  • Platelet Membrane Glycoprotein IIb

    platelet membrane glycoprotein iib is an integrin alpha subunit that heterodimerizes with integrin beta3 to form platelet glycoprotein gpiib-iiia complex. it is synthesized as a single polypeptide chain which is then postranslationally cleaved and processed into two disulfide-linked subunits of approximately 18 and 110 kda in size.
  • Platelet-Rich Plasma

    a preparation consisting of platelets concentrated in a limited volume of plasma. this is used in various surgical tissue regeneration procedures where the growth factors in the platelets enhance wound healing and regeneration.
  • Prekallikrein

    a plasma protein which is the precursor of kallikrein. plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. the absence of prekallikrein in plasma leads to fletcher factor deficiency, a congenital disease.
  • Protein Binding

    the process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. specific protein-binding measures are often used as assays in diagnostic assessments.
  • Renal Plasma Flow

    the amount of plasma that perfuses the kidneys per unit time, approximately 10% greater than effective renal plasma flow (renal plasma flow, effective). it should be differentiated from the renal blood flow; (rbf), which refers to the total volume of blood flowing through the renal vasculature, while the renal plasma flow refers to the rate of plasma flow (rpf).
  • Renal Plasma Flow, Effective

    the amount of plasma flowing to the parts of the kidney that function in the production of urine. it is the amount of plasma perfusing the kidney tubules per unit time, generally measured by p-aminohippurate clearance. it should be differentiated from renal plasma flow which is approximately 10% greater than the effective renal plasma flow.
  • Retinol-Binding Proteins, Plasma

    retinol binding proteins that circulate in the plasma. they are members of the lipocalin family of proteins and play a role in the transport of retinol from the liver to the peripheral tissues. the proteins are usually found in association with transthyretin.
  • Semen

    the thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. in addition to reproductive organ secretions, it contains spermatozoa and their nutrient plasma.
  • Serum Albumin

    a major protein in the blood. it is important in maintaining the colloidal osmotic pressure and transporting large organic molecules.
  • von Willebrand Factor

    a high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor viii/von willebrand factor complex. the von willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. it functions in adhesion of platelets to collagen and hemostatic plug formation. the prolonged bleeding time in von willebrand diseases is due to the deficiency of this factor.
  • Polygeline

    a 3.5 per cent colloidal solution containing urea-cross-linked polymerized peptides. it has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. the polymeric solution is used as a plasma expander.
  • Povidone

    a polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander.
  • Povidone-Iodine

    an iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. the iodine may be radiolabeled for research purposes.
  • Trientine

    an ethylenediamine derivative used as stabilizer for epoxy resins, as ampholyte for isoelectric focusing and as chelating agent for copper in hepatolenticular degeneration.

Coding Guidelines

Underdosing refers to taking less of a medication than is prescribed by a provider or a manufacturer's instruction. Codes for underdosing should never be assigned as principal or first-listed codes. If a patient has a relapse or exacerbation of the medical condition for which the drug is prescribed because of the reduction in dose, then the medical condition itself should be coded.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified (T45). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Table of Drugs and Chemicals

The code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
AlbuminT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Albumin
  »bovine
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Albumin
  »human serum
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Albumin
  »human serum
    »salt-poor
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Albumin
  »normal human serum
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
AminoethylisothiouriumT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Anti-anemic (drug) (preparation)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
AntihemophilicT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Antihemophilic
  »factor
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Antihemophilic
  »fraction
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Antihemophilic
  »globulin concentrate
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Antihemophilic
  »human plasma
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Antihemophilic
  »plasma, dried
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
BALT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Blood (derivatives) (natural) (plasma) (whole)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Blood (derivatives) (natural) (plasma) (whole)
  »dried
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Blood (derivatives) (natural) (plasma) (whole)
  »drug affecting NEC
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Blood (derivatives) (natural) (plasma) (whole)
  »expander NEC
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Blood (derivatives) (natural) (plasma) (whole)
  »fraction NEC
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Blood (derivatives) (natural) (plasma) (whole)
  »substitute (macromolecular)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
British antilewisiteT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Citrovorum (factor)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
CyanocobalaminT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
DeferoxamineT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
DesferrioxamineT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Dextran (40) (70) (150)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Dimercaprol (British anti-lewisite)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
DimercaptopropanolT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Edathamil disodiumT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Edetate, disodium (calcium)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
EPOT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Epoetin alphaT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
ErythropoietinT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Erythropoietin
  »human
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
FactorT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Factor
  »I (fibrinogen)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Factor
  »III (thromboplastin)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Factor
  »VIII (antihemophilic Factor) (concentrate)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Factor
  »IX complex
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Factor
  »IX complex
    »human
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Fibrinogen (human)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
FolacinT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Folic acidT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Folic acid
  »with ferrous salt
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Folic acid
  »antagonist
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Folinic acidT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Gelatin (intravenous)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Gelatin (intravenous)
  »absorbable (sponge)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
HaptendextranT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Heavy metal antidoteT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
HematinT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Hematinic preparationT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
HEST45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
HetastarchT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
HumanT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Human
  »albumin
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Human
  »growth hormone (HGH)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Human
  »immune serum
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
HydroxocobalaminT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Hydroxyethyl starchT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Leucovorin (factor)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
LiverT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Liver
  »extract
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Liver
  »extract
    »for parenteral use
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Liver
  »fraction 1
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Liver
  »hydrolysate
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
LMDT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
MecobalaminT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
NaturalT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Natural
  »blood (product)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Natural
  »gas (piped)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Natural
  »gas (piped)
    »incomplete combustion
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Normal serum albumin (human), salt-poorT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
OxypolygelatinT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Packed red cellsT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
PlasmaT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Plasma
  »expander NEC
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Plasma
  »protein fraction (human)
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
PlasmanateT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
PolygelineT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
PolyvidoneT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
PolyvinylpyrrolidoneT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
PovidoneT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Povidone
  »iodine
T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Pteroylglutamic acidT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
PVPT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Red blood cells, packedT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Saccharated iron oxideT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Trace element NECT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
TrientineT45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6
Whole blood (human)T45.8X1T45.8X2T45.8X3T45.8X4T45.8X5T45.8X6

Patient Education


Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

  • Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
  • Keeping a list of medicines.
    • Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
    • List the medicines that you are allergic to or that have caused you problems in the past.
    • Take this list with you every time you see a health care provider.
  • Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
  • Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
    • Why am I taking this medicine?
    • What are the common side effects?
    • What should I do if I have side effects?
    • When should I stop this medicine?
    • Can I take this medicine with the other medicines and supplements on my list?
    • Do I need to avoid certain foods or alcohol while taking this medicine?

Food and Drug Administration


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.